Trials / Completed
CompletedNCT03391830
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy. Randomised Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the benefit for statin use in prevention of of CI-AKI after computed tomography urogram (CTU).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin-Ascorbic acid | atorvastatin (80-mg loading dose given a mean 24 hours before procedure with another 40-mg dose approximately 2 hours before the procedure and for 3 days) plus ascorbic acid 500mg |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2018-01-15
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
- First posted
- 2018-01-05
- Last updated
- 2021-01-12
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03391830. Inclusion in this directory is not an endorsement.